However, our mutation analysis showed that the mutation rate of BRAF was less than 2.5% in ocular melanomas (UVM) (Supplementary Fig. 1), indicating that BRAF mutation may have little to do with the development of UVM and our proposed prognostic signature does not apply for non-cutaneous melanoma. This evidence concerns the gene BRAF and ocular melanoma.